1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 2: 
Bivariate analysis between baseline demographics and IAs
OutcomePatients with IAs (n = 9)Patients without IAs (n =171)P Value
Age (mean) (yr)48.1 (SD, 18.2)33.5 (SD, 21.0).042
Women7/9 (77.8%)104/171 (60.8%).486
Curaçao criteria
    Epistaxis9/9 (100%)159/171 (93.0%)1.000
    Telangiectasias8/9 (88.9%)133/171 (77.8%).687
    Pulmonary AVMs6/9 (66.7%)85/171 (49.7%).497
    Liver VMs2/9 (22.2%)12/171 (7.0%).148
    Gastrointestinal bleeding0/9 (0%)9/171 (5%)1.000
    Affected first-degree relative5/9 (55.6%)130/171 (76.0%).230
    AVM6/9 (66.7%)107/171 (62.6%)1.000
    AVF1/9 (11.1%)15/171 (8.8%).576
    AVM or AVF7/9 (77.8%)122/171 (71.3%)1.000